ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $96 | -92.3% | 30,282 | -88.0% | 0.00% | -100.0% |
Q2 2023 | $1,252 | -40.9% | 251,900 | -41.2% | 0.00% | -33.3% |
Q1 2023 | $2,118 | -23.5% | 428,700 | -2.6% | 0.00% | -25.0% |
Q4 2022 | $2,768 | -100.0% | 440,100 | -54.8% | 0.00% | -60.0% |
Q1 2022 | $8,880,000 | -51.7% | 974,700 | +38.4% | 0.01% | -56.5% |
Q2 2021 | $18,371,000 | +480.6% | 704,400 | +739.6% | 0.02% | +666.7% |
Q3 2020 | $3,164,000 | +193.2% | 83,900 | +232.9% | 0.00% | +200.0% |
Q2 2020 | $1,079,000 | – | 25,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |